Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement
|Articles|July 24, 2013

Where to Meet the Next Generation of Pharma Leaders

Publisher Russ Pratt on the Pharmaceutical Executive value proposition

Advertisement

Advertisement

Related Content

Advertisement
Pharmaceutical Executive Daily

Pharmaceutical Executive Daily: FDA Approves Ennumo

ByNicholas Jacobus
July 9th 2026
stock.adobe.com biosimilar

FDA Approves Ennumo to Decrease Incidence of Infection by Febrile Neutropenia

ByNicholas Jacobus
July 9th 2026
stock.adobe.com business deal

Pharma M&A Roundup: Chemomab Therapeutics Enters Merger Agreement with Scipher Medicine, Teva and Polpharma Biologics Enter Global Licensing Agreement

ByNicholas Jacobus
July 9th 2026
Stock.adobe.com

Pharmaceutical Executive Daily: AI as Reinvention

ByMike Hollan
July 8th 2026
Stock.adobe.com

Evogene Announces AI-Powered Small Molecule Discovery Focused Partnership with Blavatnik Center for Drug Discovery at Tel Aviv University

ByMike Hollan
July 8th 2026
Advertisement
Advertisement

Trending on PharmExec

1

Novartis to Layoff 322 NJ Employees: Report

2

Launch is Just the Beginning: Rare Disease Care Requires Durability

3

Pharma M&A Roundup: Chemomab Therapeutics Enters Merger Agreement with Scipher Medicine, Teva and Polpharma Biologics Enter Global Licensing Agreement

4

“AI as Reinvention”: Transforming the Business of Medicine

5

FDA Approves Ennumo to Decrease Incidence of Infection by Febrile Neutropenia

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us